The full survey, released Tuesday, shows that 66 percent of anesthesiologists are seeing a shortage in fentanyl, followed by thiopental (40 percent), succinylcholine (20 percent), propofol (19 percent) and pancuronium (15 percent). Anesthesiologists also noted that as a result of these shortages, patients experienced post-operative nausea and vomiting (66 percent) and longer OR and recovery times (52 percent).
Initial survey data indicated that at least seven patient deaths had occurred as a result of the nationwide anesthesia drug shortage.
Related Articles on Anesthesia:
Anesthesiologist Studies Survival Rate of Helicopter Transport Patients
Florida Gulf-to-Bay Anesthesiology Associates Partners With Private Equity Firm
Medicare ACOs Are Blooming (With or Without Anesthesiologists)
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.